COR

Cencora, Inc.

Healthcare
264.84 +0.15 +0.06% Market Closed
2026-06-02 • USD

Key Metrics

Market Cap 51.53B
EV —
Shares Out 194.56M
Revenue (ttm) 328.68B
Net Income 2.55B
Beta —
P/E 20.22
Forward P/E —
EPS (ttm) $13.05
P/S 0.16
P/B 15.16
P/FCF —
P/C —
EV/Sales —
EV/EBITDA —
ROA 3.28%
ROE 94.79%
ROIC 12.86%
Gross Margin 3.81%
Oper. Margin 0.85%
Profit Margin 0.78%
Debt/Eq 3.65
LT Debt/Eq 78.19%
Quick Ratio —
Current Ratio 0.95
Book/sh 17.46
Cash/sh 11.19
Div Yield 0.87%
Div TTM $2.30
Payout Ratio 17.62%
SMA20 -0.21%
SMA50 -10.57%
SMA200 -18.73%
Volume 1,094,660
Avg Volume 1.61M
Rel Volume —
Perf Week -1.68%
Perf Month -13.42%
Perf Quarter -26.29%
Perf Half Y -22.03%
Perf YTD -21.59%
Perf Year -8.17%
Perf 3Y 51.61%
Perf 5Y 126.51%

Factor Lens

Seasonal Performance

Dividends

Per-share amounts adjusted for stock splits.

Last Dividend $0.6000
TTM Yield 0.87%
TTM Amount $2.30
Payout Ratio 17.62%
3-Yr Growth (CAGR) 13.51%
5-Yr Growth (CAGR) 15.42%

Last 12 Payouts

Period Ex-Date Amount / Share
Q2 2026 ~2026-06-01 $0.6000
Q4 2025 ~2026-04-01 $0.5000
Q1 2025 ~2026-03-02 $0.6000
Q1 2025 ~2025-12-01 $0.6000
Q1 2025 2025-11-13 $0.6000
Q3 2025 ~2025-09-03 $0.5500
Q2 2025 ~2025-06-02 $0.5500
Q4 2024 ~2025-04-01 $0.4700
Q1 2024 ~2025-03-03 $0.5500
Q1 2024 ~2024-11-29 $0.5500
Q3 2024 ~2024-08-26 $0.5100
Q2 2024 ~2024-05-24 $0.5100

Financial Trends

Revenue & Net Income

Earnings Per Share

Margins

Cash Flow

Company Overview

Cencora is one of the largest global pharmaceutical sourcing and distribution services companies, helping both healthcare providers and pharmaceutical and biotech manufacturers improve patient access to products and enhance patient care. The company delivers innovative programs and services designed to increase the effectiveness and efficiency of the pharmaceutical supply chain in both human and animal health. Cencora distributes a comprehensive offering of brand-name, specialty brand-name, and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a wide variety of healthcare providers located in the United States and select global markets, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, physician practices, medical and dialysis clinics, veterinarians, and other customers. Additionally, the company furnishes healthcare providers and pharmaceutical manufacturers with an assortment of related services, including data analytics, outcomes research, reimbursement and pharmaceutical consulting services (including regulatory affairs, development consulting and scientific affairs, pharmacovigilance, and quality management and compliance), niche premium logistics services, inventory management, pharmacy automation, pharmacy management, and packaging solutions. The U.S. Healthcare Solutions segment distributes pharmaceuticals and provides services to healthcare providers and specialty physician practices. The International Healthcare Solutions segment focuses on international pharmaceutical wholesale and related service operations and global commercialization services.

Name
Cencora, Inc.
Industry
Medical Distribution
CEO
Robert P. Mauch · President and Chief Executive Officer
Employees
51,000 as of 2025-09-30
IPO Date
2018-09-21
Phone
(610) 727-7000
Address
1 West First Avenue, Conshohocken, PA 19428-1800
Website
—

Key Executives

Name Title FY Pay
John Ciliberto Executive Vice President and Chief Commercial Officer —
Timothy Grayson Executive Vice President and Chief Operating Officer —
Kourosh Q. Pirouz Senior Vice President, Group General Counsel and Corporate Secretary —
Marcella Bushman Executive Vice President, Chief Financial Officer —
Robert P. Mauch President and Chief Executive Officer —

Latest News